Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model-Reference-Cited by-同舟云学术

Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model

Published:2019-07-03 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Baliza Ingrid R. S.,Silva Suellen L. R.,Santos Luciano de S.,Neto João H. Araujo,Dias Rosane B.,Sales Caroline B. S.,Rocha Clarissa A. Gurgel,Soares Milena B. P.,Batista Alzir A.,Bezerra Daniel P.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado da Bahia

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference41 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin.,2018

2. Recent therapeutic advances in the treatment of colorectal cancer;Ciombor;Annu Rev Med.,2015